SGLT2 Inhibitors
Sort by:
Cardiometabolic Health Congress (CMHC)
CVOT Data in Your Clinical Practice: Patient Case and Audience Q&A
FEATURING
Robert Eckel
- 29 views
- October 22, 2019
Diabetes Updates
Best of EASD 2019: CVD Perspective
FEATURING
Peter Gaede
- 167 views
- October 23, 2019
Diabetes Updates
SGLTi and Heart Failure Prevention
FEATURING
Peter Gaede
- 339 views
- October 23, 2019
Cardiology Pulse 2019
Top 5 Cardiovascular Prevention Trials
FEATURING
Robert Chilton
- 267 views
- October 30, 2019
- 3
Cardiology Pulse 2019
Changing Landscape of CV Treatment in Type 2 Diabetes
FEATURING
Carolina Herrera
- 207 views
- October 30, 2019
- 2
Mount Sinai Advanced Innovations in Heart Failure Symposium 2019
Diabetes and Heart Failure: The New Frontier
FEATURING
Eugene Braunwald
- 47 views
- November 12, 2019
Northwestern Medicine Cardiovascular Care
15th Annual Heart Failure Holiday Symposium: Highlights and Takeaways
- 1,790 views
- January 3, 2020
- 16
Emory Diabetes Education Training Academy
Standards of Diabetes Care: Cardiovascular Disease and Risk Management
FEATURING
Guillermo Umpierrez
- 159 views
- May 15, 2020
- 1
Emory Diabetes Education Training Academy
Antihyperglycemic Medication in Type 2 Diabetes: Overall Approach
FEATURING
Guillermo Umpierrez
- 1,219 views
- May 15, 2020
- 4
Emory Diabetes Education Training Academy
Type 1 Diabetes Management: What are the Insulin Treatment Options?
FEATURING
Sonya Haw
- 232 views
- May 15, 2020
- 1
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combination Therapy
FEATURING
Guillermo Umpierrez
- 3,784 views
- May 15, 2020
- 22
Cardiometabolic Health Congress (CMHC)
COVID-19 & Obesity: Is There any Evidence that Obese Patients Have a Higher Risk of Infection? Could Obesity Be a Factor in the Death Toll in the Younger Population? Should SGLT2 Inhibitors and Other Therapies Be Discontinued Upon Hospitalization?
FEATURING
Robert Eckel
- 1,285 views
- May 22, 2020
- 10
24th Annual Heart Failure 2020: an Update on Therapy
SGLT2 Inhibitors as a Treatment for Heart Failure
FEATURING
Uri Elkayam
- 223 views
- August 27, 2020
- 2
Cardiometabolic Health Congress (CMHC)
ACC Guidelines on Diabetes, CVD & CKD: Will SGLT-2i Become a SoC in HFrEF? What Are the Major Ongoing CKD Trials?
FEATURING
Stephen D. Wiviott
- 375 views
- September 22, 2020
- 3
Cardiometabolic Health Congress (CMHC)
Q&A on Cardiorenal Protection With SGLT-2 Inhibitors in T2DM and Beyond
- 237 views
- September 22, 2020
- 2